Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Oct-24 5:23 PM View:  | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 11-Oct-24 | Market Sale (Planned) | 15,000 | $22.93 | $343,950.00 | (2%) 977.38K to 962.38K | (12%) |
| 10-Oct-24 4:36 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-24 | Payment of Exercise | 8,363 | $24.37 | $203,806.00 | (3%) 297.64K to 289.28K | (6%) |
| 10-Oct-24 4:33 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-24 | Payment of Exercise | 452 | $24.37 | $11,015.20 | (< 1%) 108.01K to 107.56K | (6%) |
| 10-Oct-24 4:31 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-24 | Payment of Exercise | 2,515 | $24.37 | $61,290.60 | (2%) 132.1K to 129.58K | (6%) |
| 23-Sep-24 4:21 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 21-Sep-24 | Payment of Exercise | 1,075 | $27.64 | $29,713.00 | (< 1%) 298.71K to 297.64K | |
| 23-Sep-24 4:15 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 21-Sep-24 | Payment of Exercise | 964 | $27.64 | $26,645.00 | (2%) 44.22K to 43.26K | |
| 23-Sep-24 4:17 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 21-Sep-24 | Payment of Exercise | 966 | $27.64 | $26,700.20 | (1%) 79.37K to 78.4K | |
| 12-Sep-24 4:09 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 11-Sep-24 | Market Sale | 2,100 | $26.17 | $54,961.20 | (2%) 110.11K to 108.01K | 2% |
| 12-Sep-24 4:11 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 11-Sep-24 | Market Sale (Planned) | 15,000 | $26.72 | $400,800.00 | (2%) 992.38K to 977.38K | 4% |
| 09-Sep-24 5:48 PM View: | Dreismann Heiner Director | Myriad Genetics Inc. (MYGN) | 09-Sep-24 | Private Sale | 10,000 | $27.05 | $270,520.00 | (8%) 131.65K to 121.65K | |
| 04-Sep-24 7:38 PM View: | Reitan Colleen F Director | Myriad Genetics Inc. (MYGN) | 03-Sep-24 | Private Sale (Planned) | 46,012 | $27.95 | $1,285,850.00 | (52%) 88.55K to 42.53K | |
| 04-Sep-24 7:51 PM View: | Fox Jennifer Lynne Chief Legal Officer | Myriad Genetics Inc. (MYGN) | 03-Sep-24 | Grant | 61,771 | -- | -- | 100% 0 to 61.77K | |
| 26-Aug-24 4:48 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 25-Aug-24 | Payment of Exercise | 217 | $28.12 | $6,102.04 | (< 1%) 44.44K to 44.22K | |
| 23-Aug-24 4:16 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 21-Aug-24 | Private Sale | 11,538 | $27.82 | $320,987.00 | (13%) 90.9K to 79.37K | |
| 20-Aug-24 4:38 PM View: | Kumar Rashmi Director | Myriad Genetics Inc. (MYGN) | 19-Aug-24 | Private Sale (Planned) | 7,500 | $28.01 | $210,075.00 | (9%) 84.89K to 77.39K | |
| 07-Jun-24 4:54 PM View: | Newcomer Lee Nisley Director | Myriad Genetics Inc. (MYGN) | 06-Jun-24 | Grant | 15,695 | -- | -- | 24% 66.65K to 82.34K | |
| 07-Jun-24 4:54 PM View: | Reitan Colleen F Director | Myriad Genetics Inc. (MYGN) | 06-Jun-24 | Grant | 15,695 | -- | -- | 22% 72.85K to 88.55K | |
| 07-Jun-24 4:54 PM View: | Kumar Rashmi Director | Myriad Genetics Inc. (MYGN) | 06-Jun-24 | Grant | 15,695 | -- | -- | 23% 69.2K to 84.89K | |
| 07-Jun-24 4:54 PM View: | Dreismann Heiner Director | Myriad Genetics Inc. (MYGN) | 06-Jun-24 | Grant | 15,695 | -- | -- | 14% 115.95K to 131.65K | |
| 10-Jun-24 4:15 PM View: | Skovronsky Daniel Director | Myriad Genetics Inc. (MYGN) | 06-Jun-24 | Grant | 15,695 | -- | -- | 22% 70.31K to 86.01K | |
| 07-Jun-24 4:53 PM View: | Bisaro Paul Director | Myriad Genetics Inc. (MYGN) | 06-Jun-24 | Grant | 15,695 | -- | -- | 64% 24.45K to 40.15K | |
| 07-Jun-24 4:53 PM View: | Phanstiel S. Louise Director | Myriad Genetics Inc. (MYGN) | 06-Jun-24 | Grant | 15,695 | -- | -- | 11% 145.07K to 160.77K | |
| 04-Jun-24 5:57 PM View: | Spiegelman Daniel K Director | Myriad Genetics Inc. (MYGN) | 04-Jun-24 | Market Sale (Planned) | 3,788 | $22.05 | $83,525.40 | (10%) 36.7K to 32.92K | (17%) |
| 04-Jun-24 5:57 PM View: | Spiegelman Daniel K Director | Myriad Genetics Inc. (MYGN) | 03-Jun-24 | Market Sale (Planned) | 3,788 | $22.04 | $83,487.50 | (9%) 40.49K to 36.7K | (17%) |
| 15-May-24 5:49 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 15-May-24 | Market Sale | 75,000 | $25.07 | $1,880,420.00 | (7%) 1.14M to 1.07M | (3%) |
| 15-May-24 5:49 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 14-May-24 | Market Sale | 95,000 | $25.21 | $2,394,800.00 | (8%) 1.24M to 1.14M | (2%) |
| 15-May-24 5:49 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 13-May-24 | Market Sale | 57,844 | $25.13 | $1,453,550.00 | (4%) 1.29M to 1.24M | (2%) |
| 15-May-24 5:48 PM View: | Newcomer Lee Nisley Director | Myriad Genetics Inc. (MYGN) | 13-May-24 | Market Sale | 6,200 | $25.30 | $156,860.00 | (9%) 72.85K to 66.65K | (2%) |
| 15-Apr-24 4:25 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 14-Apr-24 | Payment of Exercise | 1,076 | $19.55 | $21,035.80 | (< 1%) 299.79K to 298.71K | |
| 15-Apr-24 4:27 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 14-Apr-24 | Payment of Exercise | 940 | $19.55 | $18,377.00 | (< 1%) 111.05K to 110.11K | |
| 08-Apr-24 4:49 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 06-Apr-24 | Payment of Exercise | 581 | $20.26 | $11,771.10 | (1%) 45.02K to 44.44K | |
| 27-Mar-24 4:17 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 25-Mar-24 | Payment of Exercise | 363 | $21.98 | $7,978.74 | (< 1%) 45.38K to 45.02K | (17%) |
| 25-Mar-24 4:32 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 981 | $22.24 | $21,817.40 | (2%) 46.37K to 45.38K | (16%) |
| 25-Mar-24 4:30 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 45,822 | $22.24 | $1,019,080.00 | (3%) 1.34M to 1.29M | (16%) |
| 25-Mar-24 4:31 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 943 | $22.24 | $20,972.30 | (< 1%) 112.0K to 111.05K | (16%) |
| 25-Mar-24 4:31 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 2,890 | $22.24 | $64,273.60 | (2%) 134.99K to 132.1K | (16%) |
| 25-Mar-24 4:31 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 3,245 | $22.24 | $72,168.80 | (1%) 303.04K to 299.79K | (16%) |
| 25-Mar-24 4:32 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 363 | $22.24 | $8,073.12 | (< 1%) 46.73K to 46.37K | (16%) |
| 25-Mar-24 4:30 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 20,202 | $22.24 | $449,292.00 | (1%) 1.36M to 1.34M | (16%) |
| 25-Mar-24 4:31 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,405 | $22.24 | $31,247.20 | (1%) 113.4K to 112.0K | (16%) |
| 25-Mar-24 4:31 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,685 | $22.24 | $37,474.40 | (1%) 136.67K to 134.99K | (16%) |
| 25-Mar-24 4:31 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 730 | $22.24 | $16,235.20 | (< 1%) 91.63K to 90.9K | (16%) |
| 25-Mar-24 4:31 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,648 | $22.24 | $36,651.50 | (< 1%) 304.68K to 303.04K | (16%) |
| 25-Mar-24 4:32 PM View: | Wong Pamela Chief Legal Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,441 | $22.24 | $32,047.80 | (2%) 66.44K to 65.0K | (16%) |
| 18-Mar-24 4:45 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 1,585 | $21.16 | $33,538.60 | (2%) 93.22K to 91.63K | |
| 18-Mar-24 4:45 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 3,686 | $21.16 | $77,995.80 | (1%) 308.37K to 304.68K | |
| 18-Mar-24 4:46 PM View: | Wong Pamela Chief Legal Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 2,568 | $21.16 | $54,338.90 | (4%) 69.01K to 66.44K | |
| 18-Mar-24 4:44 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 30,610 | $21.16 | $647,708.00 | (2%) 1.39M to 1.36M | |
| 18-Mar-24 4:45 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 3,322 | $21.16 | $70,293.50 | (3%) 116.72K to 113.4K | |
| 18-Mar-24 4:45 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 3,306 | $21.16 | $69,955.00 | (2%) 139.98K to 136.67K |
